Bhubaneswar: Postgraduate Institute of Medical Education and Research (PGIMER) And Rajdhani Hospital Bhubaneswar Will research the use of steroids to improve outcomes in premature newborns. The World Health Organization (WHO) has selected this institution as the center for conducting the ‘WHO ACTION III trial’.
verb meaning prenatal corticosteroids For improving outcomes in preterm neonates. WHO is conducting this multi-country, multi-centre and randomized trial with two doses of antenatal corticosteroids for women. high chance of birth In the premature period in hospitals to improve the health of newborns.
The aim of this trial is to assess the benefits and potential harms of giving two regimens of antenatal corticosteroids to pregnant women between 34 and 37 weeks of gestation when they are at risk of preterm birth. Researchers will also find out which steroids are best suited to save lives immature children, Official sources said that they will also try to know about the right dosage for the safety of the mother and the child.
According to WHO, preterm infants are at risk of severe illness or death during the neonatal period. Without appropriate treatment, those who survive are at increased risk of lifelong disability and poor quality of life. It states that interventions given to the mother and to the prematurely born infant before or during pregnancy can reduce infant mortality and morbidity following premature birth.
Ayesha Mariette de Costa, Scientist, Department of Maternal, Newborn, Child and Adolescent Health, WHO, Geneva visited the Institute’s Department of Obstetrics and Gynecology and the Special Newborn Care Unit (SNCU) on 4 May. This PG Institute is the third center in the country. for this test. This research work will be done by senior doctors.
Nibedita Pani, director of the PG institute, said the WHO team has visited the institute twice to ascertain whether the hospital is suitable for testing. “Finally, WHO has sent us a confirmation letter on Saturday to start testing. This is a research of two years.
He said that this research would go a long way in solving problems related to premature birth of children.
verb meaning prenatal corticosteroids For improving outcomes in preterm neonates. WHO is conducting this multi-country, multi-centre and randomized trial with two doses of antenatal corticosteroids for women. high chance of birth In the premature period in hospitals to improve the health of newborns.
The aim of this trial is to assess the benefits and potential harms of giving two regimens of antenatal corticosteroids to pregnant women between 34 and 37 weeks of gestation when they are at risk of preterm birth. Researchers will also find out which steroids are best suited to save lives immature children, Official sources said that they will also try to know about the right dosage for the safety of the mother and the child.
According to WHO, preterm infants are at risk of severe illness or death during the neonatal period. Without appropriate treatment, those who survive are at increased risk of lifelong disability and poor quality of life. It states that interventions given to the mother and to the prematurely born infant before or during pregnancy can reduce infant mortality and morbidity following premature birth.
Ayesha Mariette de Costa, Scientist, Department of Maternal, Newborn, Child and Adolescent Health, WHO, Geneva visited the Institute’s Department of Obstetrics and Gynecology and the Special Newborn Care Unit (SNCU) on 4 May. This PG Institute is the third center in the country. for this test. This research work will be done by senior doctors.
Nibedita Pani, director of the PG institute, said the WHO team has visited the institute twice to ascertain whether the hospital is suitable for testing. “Finally, WHO has sent us a confirmation letter on Saturday to start testing. This is a research of two years.
He said that this research would go a long way in solving problems related to premature birth of children.